Palisade Bio, Inc. Common Stock

PALINASDAQUSD
1.94 USD
0.00 (0.00%)🟢PRE MARKET (AS OF 07:56 PM EDT)
🟢Market: OPEN
Open?$2.05
High?$2.17
Low?$1.96
Prev. Close?$1.96
Volume?3.2M
Avg. Volume?4.7M
VWAP?$2.04
Rel. Volume?0.68x
Bid / Ask
Bid?$1.69 × 100
Ask?$2.23 × 100
Spread?$0.54
Midpoint?$1.96
Valuation & Ratios
Market Cap?328.5M
Shares Out?167.4M
Float?148.2M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?2.54
EPS?-$0.10
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?28.95Strong
Quick Ratio?28.95Strong
Cash Ratio?28.77Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
2.54CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-10.8CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-13.0%WEAK
ROA?
-12.5%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$195.2M
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Employees
14
Market Cap
348.7M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900